The evidence for use of pneumococcal conjugate over polysaccharide in children

Abstract

Pneumococcal glycoconjugate vaccines are now used in infant immunization schedules, globally. Pneumococcal polysaccharide vaccines are still, however, advised from the second year of life to provide broader serotype coverage. The use of these polysaccharide vaccines has been under review, especially for children.

Keywords: :

• Pneumococcal
• conjugate
• polysaccharide
• vaccine

Disclosure of Potential Conflicts of Interest

No conflicts to declare.